Showing results (81-90 of 137) with videos related to

Sort By:
Pageof 14
International Journal of Environmental Research and Public Health|May 16, 2020
The Bisphenol A Induced Oxidative Stress in Non-Alcoholic Fatty Liver Disease Male Patients: A Clinical Strategy to Antagonize the Progression of the DiseaseAlessandro Federico, Marcello Dallio, Antonietta Gerarda Gravina, et al.
Cancers|June 24, 2022
Mucosal-Associated Invariant T Cells in T-Cell Non-Hodgkin Lymphomas: A Case SeriesPietro Torre, Annalisa Brescia, Giorgio Giurato, et al.
Reviews on Recent Clinical Trials|June 3, 2022
Alcoholic Consumption of Young Italians During the SARS-CoV-2 PandemicAlessandro Federico, Chiara Mazzarella, Annamaria Spina, et al.
Advances in Therapy|August 6, 2020
Real-World Clinical Practice Use of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naïve Patients with Compensated CirrhosisPietro Lampertico, Stefan Mauss, Marcello Persico, et al.
Oxidative Medicine and Cellular Longevity|November 19, 2019
Evaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters, and Serological Worsening Markers in Nonalcoholic Fatty Liver Disease PatientsAlessandro Federico, Marcello Dallio, Mario Masarone, et al.
Advances in Therapy|September 11, 2020
Correction to: Real-World Clinical Practice Use of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naïve Patients with Compensated CirrhosisPietro Lampertico, Stefan Mauss, Marcello Persico, et al.
Hepatology (Baltimore, Md.)|August 3, 2007
Suppressor of cytokine signaling 3 (SOCS3) expression and hepatitis C virus-related chronic hepatitis: Insulin resistance and response to antiviral therapyMarcello Persico, Mario Capasso, Eliana Persico, et al.
Infectious Diseases and Therapy|March 3, 2021
Addressing HCV Elimination Barriers in Italy: Healthcare Resource Utilization and Cost Impact Using 8 Weeks' Glecaprevir/Pibrentasvir TherapyMassimo Andreoni, Giovanni Di Perri, Marcello Persico, et al.
Haematologica|July 2, 2002
High prevalence of hepatitis G virus infection in Hodgkin's disease and B-cell lymphoproliferative disorders: absence of correlation with hepatitis C virus infectionAmalia De Renzo, Eliana Persico, Fedele de Marino, et al.
Antiviral Therapy|August 12, 2017
Sustained virological response by direct antiviral agents in HCV leads to an early and significant improvement of liver fibrosisMarcello Persico, Valerio Rosato, Andrea Aglitti, et al.
Pageof 14